Data sharing at a crossroads

New England Journal of Medicine

Volumn 375, Issue 12, 2016, Pages 1115-1117

  Rockhold, Frank ^a   Nisen, Perry ^b   Freeman, Andrew ^c  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b BURNHAM INSTITUTE   (United States)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACCREDITATION; CLINICAL STUDY; CLINICAL TRIAL (TOPIC); COST; DATA ANALYSIS; DATA SHARING; INFORMATION PROCESSING; INFORMATION SYSTEM; MEDICAL RESEARCH; PRIORITY JOURNAL; PRIVACY; PUBLICATION; RESOURCE MANAGEMENT; REVIEW; RISK BENEFIT ANALYSIS; SCIENTIST; ACCESS TO INFORMATION; INFORMATION DISSEMINATION;

ACCESS TO INFORMATION; CLINICAL TRIALS AS TOPIC; COSTS AND COST ANALYSIS; INFORMATION DISSEMINATION;

EID: 84988904878     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1608086     Document Type: Review

References (5)

1. Nisen P, Rockhold F. Access to patientlevel data from GlaxoSmithKline clinical trials. N Engl J Med 2013; 369: 475-8.
2. Strom BL, Buyse M, Hughes J, Knoppers BM. Data sharing, year 1-access to data from industry-sponsored clinical trials. N Engl J Med 2014; 371: 2052-4.
3. Navar AM, Pencina MJ, Rymer JA, Louzao DM, Peterson ED. Use of open access platforms for clinical trial data. JAMA 2016; 315: 1283-4.
4. Bierer BE, Li R, Barnes M, Sim I. A global, neutral platform for sharing trial data. N Engl J Med 2016; 374: 2411-3.
5. Taichman DB, Backus J, Baethge C, et al. Sharing clinical trial data-a proposal from the International Committee of Medical Journal Editors. N Engl J Med 2016; 374: 384-6.